Prospective Study to Evaluate Patient Reported Outcomes (PRO) During Rechallenge With Trabectedin in Sarcoma Patients

NCT06050434 · clinicaltrials.gov ↗
TERMINATED
Status
7
Enrollment
OTHER
Sponsor class

Stopped The study was terminated prematurely due to slow recruitment after inclusion of 7 patients (of initially planned 100 patients).

Conditions

Sponsor

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Collaborators